ICASA Satellite symposium, Wednesday 4th December 2019, 18:30 – 20:30, Room Joel Nana (AD10)

This satellite symposium will focus on innovations in molecular point-of-care technologies for HIV and Hepatitis diagnosis. Field data of the game changing Leuco-depleted SAMBA viral load POC assay and the new SAMBA HCV assay will be presented, followed by interactive discussions with the audience on challenges and rewards of POC implementation.

CO-CHAIRS:
Gary Brook, Central Middlesex Hospital, London, UK
Douglas Mangwanya, Department of Health and Child Care, Zimbabwe

Other Articles

Browse other related news and activities

NHS hospitals adopt the next-generation SAMBA to improve patient care

Leading NHS hospitals have adopted the SAMBA III rapid molecular diagnostics platform to transform the way patients with suspected respiratory infections are assessed and managed. “Using SAMBA III will give us greater flexibility meaning that our patients are cared for in the...

29 September 2025

DRW receives CTDA approval for SAMBA III respiratory molecular tests

Diagnostics for the Real World (DRW) is pleased to announce that its SAMBA III SARS-CoV-2 Test and SAMBA III SCoV-2/Flu/RSV Test have received approval under the UK Coronavirus Test Device Approvals (CTDA) process. Following a successful desktop review by the UK’s Medicines and Healthcare...

8 August 2025

The launch of SAMBA III: a new generation of rapid molecular diagnostics

Diagnostics for the Real World (DRW), a pioneer in rapid molecular diagnostics, today announces the launch of the SAMBA III Instrument System – its most advanced point-of-care molecular platform to date. Building on more than two decades of innovation, SAMBA III has...

20 April 2025

Back to News